Scott Noggle

Scott Noggle

Auto-generated profile, based on publicly available information

Scott Noggle

The New York Stem Cell Foundation Research Institute, New York, USA

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 April 2016 in Nature
Verified
Journal Article
Closed access
DPDominik Paquet
Dominik Paquet
DKDylan Kwart
Dylan Kwart
ACAntonia Chen
Antonia Chen
ASAndrew Sproul
Andrew Sproul
SJSamson Jacob
Samson Jacob
MTMarc Tessier-Lavigne
Marc Tessier-Lavigne

31 October 2016 in Nature Neuroscience
Verified
Journal Article
Open access
PDF file
JDJordane Dimidschstein
Jordane Dimidschstein
QCQian Chen
Qian Chen
RTRobin Tremblay
Robin Tremblay
SRStephanie L Rogers
Stephanie L Rogers
GSGiuseppe-Antonio Saldi
Giuseppe-Antonio Saldi
GFGord Fishell
Gord Fishell
The ability to target and manipulate specific neuronal populations is crucial for understanding brain function. In this report, the authors describe a novel virus that restricts gene expression to telencephalic GABAergic interneurons, allowing for morphological visualization, activity monitoring and functional manipulation of interneurons in mice and in non-genetically tractable species. A fundamental impediment to understanding the brain is the availability of inexpensive and robust methods for targeting and manipulating specific neuronal populations. The need to overcome this barrier is pressing because there are considerable anatomical, physiological, cognitive and behavioral differences between mice and higher mammalian species in which it is difficult to specifically target and manipulate genetically defined functional cell types. In particular, it is unclear the degree to which insights from mouse models can shed light on the neural mechanisms that mediate cognitive functions in higher species, including humans. Here we describe a novel recombinant adeno-associated virus that restricts gene expression to GABAergic interneurons within the telencephalon. We demonstrate that the viral expression is specific and robust, allowing for morphological visualization, activity monitoring and functional manipulation of interneurons in both mice and non-genetically tractable species, thus opening the possibility to study GABAergic function in virtually any vertebrate species.

1 June 2014 in Cell Stem Cell
Verified
Journal Article
Closed access
EKEvangelos Kiskinis
Evangelos Kiskinis
JSJackson Sandoe
Jackson Sandoe
LWLuis A. Williams
Luis A. Williams
GBGabriella L. Boulting
Gabriella L. Boulting
RMRob Moccia
Rob Moccia
KEKevin Eggan
Kevin Eggan

1 June 2017 in Stem Cell Reports
Verified
Journal Article
Open access
PDPanagiotis Douvaras
Panagiotis Douvaras
BSBruce Sun
Bruce Sun
MWMinghui Wang
Minghui Wang
IKIlya Kruglikov
Ilya Kruglikov
GLGregory Lallos
Gregory Lallos
VFValentina Fossati
Valentina Fossati
Microglia, the immune cells of the brain, are crucial to proper development and maintenance of the CNS, and their involvement in numerous neurological disorders is increasingly being recognized. To improve our understanding of human microglial biology, we devised a chemically defined protocol to generate human microglia from pluripotent stem cells. Myeloid progenitors expressing CD14/CX3CR1 were generated within 30 days of differentiation from both embryonic and induced pluripotent stem cells (iPSCs). Further differentiation of the progenitors resulted in ramified microglia with highly motile processes, expressing typical microglial markers. Analyses of gene expression and cytokine release showed close similarities between iPSC-derived (iPSC-MG) and human primary microglia as well as clear distinctions from macrophages. iPSC-MG were able to phagocytose and responded to ADP by producing intracellular Ca2+ transients, whereas macrophages lacked such response. The differentiation protocol was highly reproducible across several pluripotent stem cell lines.

8 January 2021 in Science Advances
Verified
Journal Article
Open access
PDF file
RNRyan A. Neff
Ryan A. Neff
MWMinghui Wang
Minghui Wang
SVSezen Vatansever
Sezen Vatansever
LGLei Guo
Lei Guo
CMChen Ming
Chen Ming
BZBin Zhang
Bin Zhang
Alzheimer’s disease (AD), the most common form of dementia, is recognized as a heterogeneous disease with diverse pathophysiologic mechanisms. In this study, we interrogate the molecular heterogeneity of AD by analyzing 1543 transcriptomes across five brain regions in two AD cohorts using an integrative network approach. We identify three major molecular subtypes of AD corresponding to different combinations of multiple dysregulated pathways, such as susceptibility to tau-mediated neurodegeneration, amyloid-β neuroinflammation, synaptic signaling, immune activity, mitochondria organization, and myelination. Multiscale network analysis reveals subtype-specific drivers such as GABRB2, LRP10, MSN, PLP1, and ATP6V1A. We further demonstrate that variations between existing AD mouse models recapitulate a certain degree of subtype heterogeneity, which may partially explain why a vast majority of drugs that succeeded in specific mouse models do not align with generalized human trials across all AD subtypes. Therefore, subtyping patients with AD is a critical step toward precision medicine for this devastating disease.

3 August 2015 in Nature Methods
Verified
Journal Article
Closed access
PDF file
DPDaniel Paull
Daniel Paull
Ana SevillaAna Sevilla
Ana Sevilla
HZHongyan Zhou
Hongyan Zhou
AHAana Kim Hahn
Aana Kim Hahn
HKHesed Kim
Hesed Kim
SNScott A Noggle
Scott A Noggle